Covidh Technologies Ltd has announced a ₹8.09 crore rights issue, offering 80.85 lakh equity shares at ₹10 each. The entitlement ratio is set at 25:1, with the issue opening on November 3 and closing on November 10, 2025. The move aims to strengthen capital structure and support future growth initiatives.
Covidh Technologies Ltd has unveiled a significant capital-raising initiative through a rights issue worth ₹8.09 crore, aimed at bolstering its financial base and funding strategic growth. The company will issue 80,85,550 fully paid-up equity shares at a face value of ₹10 per share, with a rights entitlement ratio of 25:1, meaning shareholders will receive 25 new shares for every 1 share held.
🧾 Major Takeaways:
Issue Details: The rights issue is priced at ₹10 per share, aggregating to ₹8,08,55,500. This represents a substantial increase in the company’s share capital from 3,23,422 to 84,08,972 shares, assuming full subscription.
Entitlement Ratio: Shareholders will be entitled to 25 equity shares for every 1 share held as of the record date, which is set for October 24, 2025.
Issue Timeline:
Opening Date: November 3, 2025
Closing Date: November 10, 2025
Rights Entitlements: Will be credited to eligible shareholders’ demat accounts prior to the issue opening.
Purpose of the Issue: The capital raised will be used to enhance working capital, fund expansion plans, and strengthen the company’s balance sheet, positioning Covidh Technologies for long-term scalability.
Shareholder Impact: The rights issue offers existing shareholders an opportunity to increase their holdings at a discounted price, potentially improving liquidity and market participation.
Corporate Strategy: This move aligns with Covidh’s broader strategy to capitalize on growth opportunities in the IT and digital services space, while maintaining a lean capital structure.
📌 Notable Updates:
The rights issue is expected to improve the company’s equity base and reduce dependence on external borrowings.
Analysts view the deep discount and high entitlement ratio as a shareholder-friendly move, though dilution risk remains for non-participating investors.
With a compelling offer structure and clear strategic intent, Covidh Technologies is positioning itself for accelerated growth and operational resilience in the evolving tech landscape.
Sources: 1. ScanX News – Rights Issue Announcement 2. SEBI Filing – Rights Issue Approval 3. Financial Express – Rights Issue Overview